Aclaris Therapeutics (ACRS) Other Non-Current Assets (2014 - 2026)

Aclaris Therapeutics' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 24.85% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (down 24.85% YoY), while the FY2025 annual figure was $2.8 million, down 9.62% from the prior year.
• Other Non-Current Assets was $2.4 million for Q1 2026 at Aclaris Therapeutics, down from $2.8 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.2 million in Q4 2023 to a low of $2.4 million in Q1 2026.
• Historically, Other Non-Current Assets has averaged $3.1 million across 5 years, with a median of $3.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 52.2% in 2023, then fell 26.26% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $2.7 million in 2022, then soared by 52.2% to $4.2 million in 2023, then dropped by 26.26% to $3.1 million in 2024, then decreased by 9.62% to $2.8 million in 2025, then slipped by 14.54% to $2.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.4 million (Q1 2026), $2.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.